FDA Inspection 1165170 — Daniel V Alfaro, MD

Daniel V Alfaro, MD — FEI 3021245697

The FDA completed an inspection of Daniel V Alfaro, MD on Mar 17, 2022 in Ladson, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 17, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ladson, SC (United States)

Additional Details

Clinical Investigator (CI)